ENCODE cell lines, expression (Ernst 2011)
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr22_+_23229960 | 6.91 |
ENST00000526893.1 ENST00000532223.2 ENST00000531372.1 |
IGLL5 |
immunoglobulin lambda-like polypeptide 5 |
chr22_+_23101182 | 4.52 |
ENST00000390312.2 |
IGLV2-14 |
immunoglobulin lambda variable 2-14 |
chr5_-_149792295 | 4.31 |
ENST00000518797.1 ENST00000524315.1 ENST00000009530.7 ENST00000377795.3 |
CD74 |
CD74 molecule, major histocompatibility complex, class II invariant chain |
chr22_+_23134974 | 3.99 |
ENST00000390314.2 |
IGLV2-11 |
immunoglobulin lambda variable 2-11 |
chr6_-_167369612 | 3.84 |
ENST00000507747.1 |
RP11-514O12.4 |
RP11-514O12.4 |
chr22_+_23165153 | 3.68 |
ENST00000390317.2 |
IGLV2-8 |
immunoglobulin lambda variable 2-8 |
chr14_+_105953204 | 3.64 |
ENST00000409393.2 |
CRIP1 |
cysteine-rich protein 1 (intestinal) |
chr14_+_105953246 | 3.48 |
ENST00000392531.3 |
CRIP1 |
cysteine-rich protein 1 (intestinal) |
chr22_+_23241661 | 3.46 |
ENST00000390322.2 |
IGLJ2 |
immunoglobulin lambda joining 2 |
chr11_+_121447469 | 3.45 |
ENST00000532694.1 ENST00000534286.1 |
SORL1 |
sortilin-related receptor, L(DLR class) A repeats containing |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 14.3 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.6 | 13.6 | GO:0015929 | hexosaminidase activity(GO:0015929) |
3.2 | 9.6 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.1 | 9.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.5 | 8.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.3 | 7.1 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.2 | 5.2 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 5.2 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 5.0 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.3 | 4.9 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 12.9 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
2.4 | 9.6 | GO:0002086 | maltose metabolic process(GO:0000023) diaphragm contraction(GO:0002086) |
0.9 | 9.0 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.6 | 8.4 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.3 | 8.4 | GO:0006884 | cell volume homeostasis(GO:0006884) |
1.1 | 7.7 | GO:0018158 | protein oxidation(GO:0018158) |
0.4 | 7.3 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
1.0 | 6.1 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
1.5 | 6.0 | GO:0043323 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
0.1 | 5.9 | GO:0046324 | regulation of glucose import(GO:0046324) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 17.4 | GO:0042571 | immunoglobulin complex(GO:0019814) immunoglobulin complex, circulating(GO:0042571) |
0.5 | 11.4 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 9.2 | GO:0009897 | external side of plasma membrane(GO:0009897) |
1.0 | 7.8 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.4 | 6.7 | GO:0042627 | chylomicron(GO:0042627) |
0.9 | 6.3 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.3 | 6.0 | GO:0001891 | phagocytic cup(GO:0001891) |
0.5 | 5.6 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 5.1 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
1.6 | 4.9 | GO:0071745 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 12.9 | PID BCR 5PATHWAY | BCR signaling pathway |
0.2 | 10.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.3 | 9.5 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.3 | 6.8 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 6.0 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 5.5 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 4.4 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 2.5 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 2.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 2.3 | PID IL12 2PATHWAY | IL12-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 43.6 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
2.0 | 9.8 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
2.4 | 9.5 | GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling(GO:0010903) |
0.2 | 8.6 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 8.4 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.3 | 6.9 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
1.4 | 5.6 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
1.0 | 5.0 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.2 | 4.8 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 4.8 | GO:0031295 | T cell costimulation(GO:0031295) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 18.8 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 8.1 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 7.9 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.2 | 5.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 5.6 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.3 | 5.3 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 5.2 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.4 | 4.8 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.2 | 4.4 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 4.3 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 29.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 15.6 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.2 | 11.0 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 6.4 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 4.9 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 4.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 4.8 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 4.5 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 4.2 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 3.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 10.1 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.4 | 9.7 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.3 | 8.9 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 8.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 6.4 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 6.1 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.4 | 5.9 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.2 | 4.4 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 4.3 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 4.1 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 25.9 | GO:0043202 | lysosomal lumen(GO:0043202) |
1.9 | 13.1 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
0.0 | 12.7 | GO:0005938 | cell cortex(GO:0005938) |
0.1 | 11.8 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 9.4 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 8.5 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 7.7 | GO:0005901 | caveola(GO:0005901) |
0.7 | 6.9 | GO:0097413 | Lewy body(GO:0097413) |
0.8 | 6.7 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.1 | 6.2 | GO:0016235 | aggresome(GO:0016235) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 28.7 | GO:0003823 | antigen binding(GO:0003823) |
0.4 | 22.3 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
2.4 | 9.5 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.5 | 9.1 | GO:0003680 | AT DNA binding(GO:0003680) |
1.0 | 7.6 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.4 | 6.9 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 6.5 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.2 | 5.6 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 5.4 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.6 | 4.4 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |